Abstract
Purpose
This study was designed to evaluate the electromagnetic interference (EMI) effects and safety of the new security screening millimetre wave body scanners (MWBSs) for patients with rare cardiac implantable electronic devices (CIEDs).
Methods
We identified 73 patients with either entirely subcutaneous implantable cardioverter-defibrillators (S-ICD) or leadless pacemakers (LPM) attending routine device follow-up. CIED programming was optimised for the detection of EMI occurrence, and high-voltage therapy was disabled. Patients then underwent millimetre wave body scans under continuous ECG monitoring. Scanning was performed at the recommended distance as well as in close proximity to the scanner emulating accidental exposure. CIED function was observed for EMI effects.
Results
There were no episodes of inhibition of pacing in the leadless pacemaker subgroup, no oversensing in the S-ICD subgroup and no spontaneous device reprogramming in any group. There was no change in pacing or sensing thresholds, and S-ICD vector eligibility remained unchanged after scanning with the MWBS. No CIEDs were identified by the MWBS during the study.
Conclusion
No EMI events were detected during the use of MWBSs by patients with either S-ICDs or LPMs. This data should be reassuring for patients suggesting that they can undergo security body scans without worries or disclosure of their CIED status.
Similar content being viewed by others
Availability of data and material
Not applicable.
Code availability
Not applicable.
References
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med. 2010;363(1):36–44.
Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–867.
O’Connor M, et al. Long-term single-center comparison of ICD lead survival: evidence for premature Linox lead failure. J Cardiovasc Electrophysiol. 2018;29(7):1024–31.
Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–80.
Borleffs CJW, van Erven L, van Bommel RJ, van der Velde ET, van der Wall EE, Bax JJ, et al. Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythm Electrophysiol. 2009;2(4):411–6.
Hauser RG, et al. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2002;25(6):879–82.
Kitamura S, Satomi K, Kurita T, Shimizu W, Suyama K, Aihara N, et al. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J. 2006;70(3):273–7.
Dorwarth U, et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14(1):38–43.
Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation. 2013;128(25):2799–809.
Dawson TW, Caputa K, Stuchly MA, Shepard RB, Kavet R, Sastre A. Pacemaker interference by magnetic fields at power line frequencies. IEEE Trans Biomed Eng. 2002;49(3):254–62.
Scholten A, Silny J. The interference threshold of unipolar cardiac pacemakers in extremely low frequency magnetic fields. J Med Eng Technol. 2001;25(5):185–94.
Misiri J, Kusumoto F, Goldschlager N. Electromagnetic interference and implanted cardiac devices: the nonmedical environment (part I). Clin Cardiol. 2012;35(5):276–80.
StJude, “ICD and Pacemaker Interference: Dealing With EMI.” [Online]. Available: https://www.sjm.com/en/patients/arrhythmias/living-with-your-treatment/electromagnetic-interference?alert=DeepLinkSoftAlert&clset=af584191-45c9-4201-8740-5409f4cf8bdd%3Ab20716c1-c2a6-4e4c-844b-d0dd6899eb3a. [Accessed: 05-Sep-2017].
Medtronic, “Answers to Questions about Implantable Cardiac Devices, electromagnetic compatability guide,” 2016. [Online]. Available: http://www.medtronic.com/content/dam/medtronic-com-m/mdt/documents/emc_guide.pdf. [Accessed: 05-Sep-2016].
Rohde and Schwarz, “R+S QPS Quick Personnel Security Scanner.” [Online]. Available: https://cdn.rohde-schwarz.com/pws/dl_downloads/dl_common_library/dl_brochures_and_datasheets/pdf_1/QPS100-200_bro_en_3606-7160-12_v0200.pdf. [Accessed: 14-Aug-2018].
Jilek C, Tzeis S, Vrazic H, Semmler V, Andrikopoulos G, Reents T, et al. Safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices: a cross-sectional analysis. Ann Intern Med. 2011;155(9):587–92.
Kolb C, Schmieder S, Lehmann G, Zrenner B, Karch MR, Plewan A, et al. Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol. 2003;41(11):2054–9.
Guag J, Addissie B, Witters D. Personal medical electronic devices and walk-through metal detector security systems: assessing electromagnetic interference effects. Biomed Eng Online. 2017;16(1):33.
Lennerz C, O’Connor MJ, Blažek P, Weigand S, Grebmer C, Reif S, et al. Modern security screening and electromagnetic interference with cardiac implantable electronic devices. J Am Coll Cardiol. 2020;75(10):1238–9.
Lennerz C, Pavaci H, Grebmer C, Semmler V, Bourier F, Haller B, et al. Electromagnetic interference in cardiac implantable electronic devices. J Am Coll Cardiol. 2017;69(1):108–10.
Wu T, Rappaport TS, and Collins CM (2005) “The human body and millimeter-wave wireless communication systems: interactions and implications,” in 2015 IEEE International Conference on Communications (ICC), pp. 2423–2429.
Funding
This work was supported by the Bavarian Ministry of Economic Affairs, Energy and Technology [Nr. 07 03/686 68/ 57 /17/ 30 /18/ 31 /19)]. Rohde & Schwarz provided a millimetre wave body scanner (R&S QPS, Rohde & Schwarz, Germany) for use during the study.
Author information
Authors and Affiliations
Contributions
Conceptualization: Christof Kolb and Carsten Lennerz.
Methodology: Tilko Reents, Marc Kottmaier, Lena Friedrich and Christof Kolb.
Formal analysis and investigation: Patrick Blažek, Severin Weigand, Christian Grebmer, Sebastian Reif and Stephanie Fichtner.
Writing—original draft preparation: Matthew J O’Connor and Carsten Lennerz.
Writing—review and editing: Felix Bourier, Verena Semmler, Isabel Deisenhofer, Heribert Schunkert and Christof Kolb.
Funding acquisition: Heribert Schunkert and Carsten Lennerz.
Resources: Isabel Deisenhofer, Heribert Schunkert and Christof Kolb.
Supervision: Isabel Deisenhofer, Christof Kolb and Carsten Lennerz.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of Technische Universität München, Munich.
Consent to participate
All participants provided full, written, informed consent to participation.
Consent for publication
All participants provided full, written, informed consent to publication.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Blažek, P., O’Connor, M.J., Weigand, S. et al. Security millimetre wave body scanner safe for patients with leadless pacemakers or subcutaneous implantable cardioverter-defibrillators. J Interv Card Electrophysiol 61, 603–607 (2021). https://doi.org/10.1007/s10840-020-00830-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-020-00830-x